Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sotatercept
Pharma
After trial success, Merck halts a different Winrevair study
For "ethical" reasons, Merck has halted a trial of its PAH treatment Winrevair after reviewing positive interim results from another ongoing study.
Kevin Dunleavy
Jan 30, 2025 6:45am
Survey indicates Merck's Winrevair is set for 'strong uptake'
Jan 24, 2025 11:52am
Merck preps filings after Winrevair succeeds in severe PAH study
Nov 25, 2024 9:00am
As Gardasil sales fall in China, Merck has few answers why
Jul 30, 2024 11:53am
Merck touts newly approved Winrevair as example of BD acumen
Apr 25, 2024 11:06am
FDA signs off on Merck’s potential blockbuster Winrevair for PAH
Mar 26, 2024 5:11pm
